Significant correlation between the CD63 assay and the histamine release assay in chronic urticaria

British Journal of Dermatology

Volumn 155, Issue 1, 2006, Pages 67-75

  Szegedi, A ^a   Irinyi, B ^a   Gal M ^a   Hunyadi, J ^a   Danko K ^a   Kiss, E ^a   Sipka, S ^a,b   Szegedi, G ^a,b   Gyimesi, E ^a,b  

^a UNIVERSITY OF DEBRECEN   (Hungary)

^b INSTITUTE OF EXPERIMENTAL MEDICINE   (Hungary)

Author keywords

CD63 assay; Chronic urticaria; Flow cytometry; Histamine release; Soluble CD40 ligand

Indexed keywords

CD40 LIGAND; CD63 ANTIGEN; HISTAMINE;

ADOLESCENT; ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; AUTOIMMUNE DISEASE; BASOPHIL; CD63 ASSAY; CHRONIC URTICARIA; CONTROLLED STUDY; DONOR; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; FUNCTION TEST; HISTAMINE RELEASE; HISTAMINE RELEASE ASSAY; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SERUM; UPREGULATION;

ADOLESCENT; ADULT; AGED; ANALYSIS OF VARIANCE; ANTIGENS, CD; BASOPHILS; BIOLOGICAL ASSAY; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CD40 LIGAND; CHRONIC DISEASE; FEMALE; HISTAMINE RELEASE; HUMANS; LYMPHOCYTE ACTIVATION; MALE; MIDDLE AGED; PLATELET MEMBRANE GLYCOPROTEINS; SKIN TESTS; STATISTICS, NONPARAMETRIC; URTICARIA;

EID: 33745019864     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2006.07205.x     Document Type: Article

References (38)

1. Kaplan AP. Chronic urticaria: pathogenesis and treatment. J Allergy Clin Immunol 2004 114: 465 74.
2. Sabroe A Greaves MW. The pathogenesis of chronic idiopathic urticaria. Arch Dermatol 1997 133: 1003 8.
3. Greaves MW. Chronic idiopathic urticaria. Curr Opin Allergy Clin Immunol 2003 3: 363 8.
4. Hide M Francis DM Grattan CEH et al. Autoantibodies against the high-affinity IgE receptor as a cause of histamine release in chronic urticaria. N Engl J Med 1993 328: 1599 604.
5. Grattan CEH Francis DM Hide M Greaves MW. Detection of circulating histamine releasing autoantibodies with functional properties of anti-IgE in chronic urticaria. Clin Exp Allergy 1991 21: 695 704.
6. Greaves MW. Chronic urticaria. J Allergy Clin Immunol 2000 105: 664 72.
7. Grattan CEH Wallington TB Warin RP. A serological mediator in chronic idiopathic urticaria - a clinical, immunological and histological evaluation. Br J Dermatol 1986 114: 583 90.
8. Gruber BL Baeza M Marchese M et al. Prevalence and functional role of anti-IgE autoantibodies in urticaria syndromes. J Invest Dermatol 1988 90: 213 17.
9. Sabroe RA Seed PT Francis DM et al. Chronic idiopathic urticaria: comparison of the clinical features of patients with and without anti-FcεRI or anti-IgE autoantibodies. J Am Acad Derm 1999 40: 443 50.
10. Grattan CEH. Autoimmune urticaria. Immunol Allergy Clin N Am 2004 24: 163 81.
11. Fiebiger E Hammerschmid F Stingl G Maurer D. Anti-FcεRIα autoantibodies in autoimmune-mediated disorders. Identification of a structure-function relationship. J Clin Invest 1998 101: 243 51.
12. Sabroe RA Grattan CEH Francis DM et al. The autologous serum skin test: a screening test for autoantibodies in chronic idiopathic urticaria. Br J Dermatol 1999 140: 446 52.
13. Kikuchi Y Kaplan AP. Mechanisms of autoimmune activation of basophils in chronic urticaria. J Allergy Clin Immunol 2001 107: 1056 62.
14. Knol EF Mul FP Jansen H et al. Monitoring human basophil activation via CD63 monoclonal antibody 435. J Allergy Clin Immunol 1991 88: 328 38.
15. Gyimesi E Sipka S Dankó K et al. Basophil CD63 expression assay on highly sensitized atopic donor leucocytes - a useful method in chronic autoimmune urticaria. Br J Dermatol 2004 151: 388 96.
16. de Swerdt A van den Keybus C Kasran A et al. Detection of basophil-activating IgG autoantibodies in chronic idiopathic urticaria by induction of CD63. J Allergy Clin Immunol 2005 116: 662 7.
17. Crow MK Kirou KA. Regulation of CD40 ligand expression in systemic lupus erythematosus. Current Opin Rheumatol 2001 13: 361 9.
18. Vakkalanka RK Woo C Kirou KA et al. Elevated level and functional capacity of soluble CD40 ligand in systemic lupus erythematosus sera. Arthritis Rheum 1999 42: 871 81.
19. Tamura N Kobayashi S Kato K et al. Soluble CD154 in rheumatoid arthritis: elevated plasma levels in cases with vasculitis. J Rheumatol 2001 28: 2583 90.
20. Jinnin M Ihn H Yazawa N et al. Elevated circulating soluble CD40 ligand in patients with mixed connective tissue disease. Clin Rheumatol 2003 22: 37 9.
21. Komura K Sato S Hasegawa M et al. Elevated circulating CD40L concentrations in patients with systemic sclerosis. J Rheumatol 2004 31: 514 19.
22. Toubi E Adir-Shani A Kessel A et al. Immune aberrations in B and T lymphocytes derived from chronic urticaria patients. J Clin Immunol 2000 20: 371 8.
23. Wedi B Novacovic V Koerner M Kapp A. Chronic urticaria serum induces histamine release, leukotriene production, and basophil CD63 surface expression - inhibitory effects of anti-inflammatory drugs. J Allergy Clin Immunol 2000 105: 552 60.
24. Sainte-Laudy J Sabbah A Drouet M et al. Diagnosis of venom allergy by flow cytometry. Correlation with clinical history, skin test, specific IgE, histamine and leukotriene C4 release. Clin Exp Allergy 2000 31: 1166 71.
25. Sanz ML Sanchez G Gamboa PM et al. Allergen-induced basophil activation: CD63 cell expression detected by flow cytometry in patients allergic to Dermatophagoides pteronyssinus and Lolium perenne. Clin Exp Allergy 2001 31: 975 7.
26. Sainte-Laudy J Sabbah A Vallon C Guerin JC. Analysis of anti-IgE and allergen induced human basophil activation by flow cytometry. Comparison with histamine release. Inflamm Res 1998 47: 401 8.
27. Paris-Kohler A Demoly P Persi L et al. In vitro diagnosis of cypress pollen allergy by using cytofluorimetric analysis of basophils (Basotest). J Allergy Clin Immunol 2000 105: 339 45.
28. Lambert C Guilloux L Dzviga C et al. Flow cytometry versus histamine release analysis of in vitro basophil degranulation in allergy to Hymenoptera venom. Cytometry B Clin Cytom 2003 52: 13 19.
29. Sanz ML Gamboa PM Garcia-Aviles C et al. Flow cytometric cellular allergen stimulation test in latex allergy. Int Arch Allergy Immunol 2003 130: 33 9.
30. Monneret G Dumenil V Benoit Y et al. Biological diagnosis of immediate drug allergy. Comparative study of histamine liberation tests and CD63 expression by flow cytometry (preliminary results). Allergy Immunol (Paris) 1999 31: 307 10.
31. Sabroe RA Fiebiger E Francis DM et al. Classification of anti-FcεRI and anti-IgE autoantibodies in chronic idiopathic urticaria and correlation with disease severity. J Allergy Clin Immunol 2002 110: 492 9.
32. Bochner BS. Systemic activation of basophils and eosinophils: markers and consequences. J Allergy Clin Immunol 2000 106: S292 302.
33. Casolaro V Spadaro G Marone G. Human basophil releasability. VI. Changes in basophil releasability in patients with allergic rhinitis or bronchial asthma. Am Rev Respir Dis 1990 142: 1108 11.
34. Sin AZ Roche EM Togias A et al. Nerve growth factor or IL-3 induces more IL-13 production from basophils of allergic subjects than from basophils of nonallergic subjects. J Allergy Clin Immunol 2001 108: 387 93.
35. Asero R Lorini M Chong SU et al. Assessment of histamine-releasing activity of sera from patients with chronic urticaria showing positive autologous skin test on human basophils and mast cells. Clin Exp Allergy 2004 34: 1111 14.
36. Kato K Santana-Sahagún E Rassenti LZ et al. The soluble CD40 ligand sCD154 in systemic lupus erythematosus. J Clin Invest 1999 104: 947 55.
37. Garmendia JV Zabaleta M Blanca I et al. Total and biologically active serum-soluble CD154 in patients with chronic idiopathic urticaria. Allergy and Asthma Proc 2004 25: 121 5.
38. Henz BM Maurer M Lippert U et al. Mast cells as initiators of immunity and host defense. Exp Dermatol 2001 10: 1 10.